Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019056-24-000080
Filing Date
2024-02-14
Accepted
2024-02-14 17:04:58
Documents
2
Group Members
A. GLENN HELMERSCONDAGUA, LLCJOHN B. HELMERSLONG FOCUS CAPITAL MANAGEMENT, LLCLONG FOCUS CAPITAL MASTER, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A adaptimmune_13ga1.htm SC 13G/A 131539
2 EXHIBIT 1 ex_1.htm EX-1 12942
  Complete submission text file 0001019056-24-000080.txt   146458
Mailing Address 207 CALLE DEL PARQUE A&M TOWER 8TH FLOOR SAN JUAN PR 00912
Business Address 207 CALLE DEL PARQUE A&M TOWER 8TH FLOOR SAN JUAN PR 00912 864-990-3233
Long Focus Capital Management, LLC (Filed by) CIK: 0001602716 (see all company filings)

EIN.: 462772035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Subject) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88833 | Film No.: 24640257
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)